drugset / Trial / NCT03396900

Periodontally Accelerated Osteogenic Orthodontics With BMP2

NCT03396900 ↗

Phase 2 Completed 30 enrolled SVS Institute of Dental Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

rhBMP-2 has the potential to function as a regenerative material in periodontally accelerated osteogenic orthodontics (PAOO). This study aimed to assess the effects of PAOO with BMP-2 on outcomes such as treatment period, bone density, healing and pain.

Timeline

Start
2016-07-01
Primary completion
2017-08-01
Completion
2017-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator RhBMP-2 Protein, Recombinant Protein / enzyme biologic 0.5 ug/ml —